Isc10, an inhibitor of the Smk1 MAPK, prevents activation loop autophosphorylation and substrate phosphorylation

Abhimannyu Rimal1, Thomas M Swayne1, Zeal P Kamdar1

  • 1Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Insights

A novel inhibitor, Isc10, controls yeast Smk1 (mitogen-activated protein kinase) activity by blocking its self-phosphorylation and substrate phosphorylation via distinct mechanisms, suggesting conserved regulation in eukaryotes.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Eukaryotic protein kinases, including yeast Smk1 (a meiosis-specific MAPK), are often activated by autophosphorylation of their activation loop.
  • Smk1 activity is regulated by inhibitor Isc10 during meiosis I and activator Ssp2 during meiosis II.
  • Isc10 degradation and Smk1 autophosphorylation are required for spore formation post-meiosis.

Purpose of the Study:

  • To elucidate the mechanism by which Isc10 inhibits Smk1 activity.
  • To identify the specific domain of Isc10 responsible for Smk1 inhibition.
  • To investigate whether the inhibitory mechanism is conserved in mammalian kinases.

Main Methods:

  • Bacterial coexpression and in vitro reconstitution system to study Smk1-Isc10 interactions.
  • Site-directed mutagenesis to define the inhibitory domain of Isc10.
  • In vitro kinase assays to assess Smk1 autophosphorylation and substrate phosphorylation.
  • Testing Isc10 inhibition on mammalian intestinal cell kinase (ICK1/CILK1).

Main Results:

  • A specific inhibitory domain within the carboxy-terminal half of Isc10 was identified.
  • Isc10 inhibits Smk1 autophosphorylation via one mechanism and substrate phosphorylation via a separate mechanism.
  • Smk1 phosphorylates Isc10 at serine 97, and this phosphorylation event inhibits the Smk1 active site.
  • Isc10 also inhibits the autophosphorylation of the mammalian kinase ICK1 (CILK1).

Conclusions:

  • Isc10 employs distinct mechanisms to inhibit Smk1 autophosphorylation and substrate phosphorylation.
  • Phosphorylation of Isc10 at Ser97 is crucial for its inhibitory function.
  • The findings reveal a conserved mechanism for regulating MAPK-like enzymes, identifying a novel class of developmental regulators.
  • This study provides insights into the precise molecular control of meiosis-specific MAPK signaling.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K